Combination Therapy of SyB C-1101 and Azacytidine in Patients With Myelodysplastic Syndrome

NCT02783547 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped The trial was withdrawn due to problems with the manufacture of the investigational drug.

Conditions

Interventions

Sponsor

SymBio Pharmaceuticals